Cowen analyst Boris Peaker downgraded ERYTECH Pharma SA. (NASDAQ: ERYP) from Outperform to Market Perform.The analyst commented, "Erytech announced that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE